Survival and Hematologic Benefits of Romiplostim After Acute Radiation Exposure Supported FDA Approval Under the Animal Rule.

导出原文传递

翻译打印收藏纠错

作者： Deborah I,Bunin ^[1] ; Harold S,Javitz ^[1] ; Janet,Gahagen ^[1] ; James,Bakke ^[1] ; Joan H,Lane ^[2] ; Dina A,Andrews ^[2] ; Polly Y,Chang ^[3]

作者单位： SRI Biosciences, SRI International, Menlo Park, California. ^[1] Amgen Inc, Thousand Oaks, California. ^[2] SRI Biosciences, SRI International, Menlo Park, California. Electronic address: polly.chang@sri.com. ^[3]

主题词成年人(Adult);动物(Animals);人类(Humans);男(雄)性(Male);女(雌)性(Female);儿童(Child);猕猴(Macaca mulatta);重组蛋白质类(Recombinant Proteins);血小板减少(Thrombocytopenia);中性粒细胞减少(Neutropenia);血液学(Hematology)

DOI 10.1016/j.ijrobp.2023.05.008

PMID 37224926

发布时间 2023-09-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览3

International journal of radiation oncology, biology, physics

2023年117卷3期

705-717页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Survival and Hematologic Benefits of Romiplostim After Acute Radiation Exposure Supported FDA Approval Under the Animal Rule.

International journal of radiation oncology, biology, physics

相似文献

International journal of radiation oncology, biology, physics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Survival and Hematologic Benefits of Romiplostim After Acute Radiation Exposure Supported FDA Approval Under the Animal Rule.

International journal of radiation oncology, biology, physics

相似文献

International journal of radiation oncology, biology, physics

相关期刊

检索历史清除